40V
SGXiX Biopharma Ltd
Health CareSingapore
Financial Summary
| Metric | FY20 | FY17 |
|---|---|---|
| Revenue | $0 | $15.0M |
| EBITDA | - | - |
| Net Profit | $59.7M | $0 |
| EPS | - | - |
| DPS | - | - |
Balance Sheet
Total Assets$63.6M
Total Liabilities-
Equity$62.9M
Net Debt$-42.2M
Cash$42.8M
NTA/Share-
FY20
Price Chart
Insufficient price data
Key Metrics
P/E Ratio-
P/B Ratio1.22
EV/EBITDA-1.64
Dividend Yield-
ROE-25.1%
ROA-15.2%
Net Margin0.0%
Debt/Equity0.01
Net Debt/EBITDA-
FCF Yield-
Governance Score
-
SGX Code of Corporate Governance
StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.